Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker—Results from a 1-yr, Multicentre, Randomised, Phase 2 Dosage-Finding Study in the Treatment of Prostate Cancer

Estimates of the cancer incidence and mortality in Europe in 2006

Jacques Ferlay, Philippe Autier, Mathieu Boniol et al. · Annals of Oncology · 2007 · 4K citations · Full text

Medicine, Oncology, Cancer Epidemiology +11

Guidelines on Prostate Cancer

Axel Heidenreich, Joaquim Bellmunt, M. Bolla et al. · 2013 · 864 citations

Medicine, Oncology, Urology +12

GnRH-receptor interaction. V. Down-regulation of pituitary receptors for GnRH in ovariectomized ewes by infusion of homologous hormone.

Nett Tm, Crowder Me, Moss Ge et al. · PubMed · 1981 · 168 citations

Life Sciences, Animal Sciences, Endocrinology +12

A phase 3, multicenter, open-label, randomized study of abarelix versus leuprolide acetate in men with prostate cancer

David G. McLeod, Norman R. Zinner, Kevin M. Tomera et al. · Urology · 2001 · 164 citations

Medicine, Pharmacology, Urology +11

Pharmacological Profile of a New, Potent, and Long-Acting Gonadotropin-Releasing Hormone Antagonist: Degarelix

Pierre Broqua, Pierre Rivière, P. Michael Conn et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 151 citations · Full text

Medicine, Endocrinology, Pharmacology +17